We are live on ! Find out more
DKCM

Davidson Kempner Capital Management Portfolio holdings

AUM $7.33B
1-Year Est. Return 56.47%
This Fund
S&P 500
This Quarter Est. Return
+8.4%
1 Year Est. Return
+56.47%
3 Year Est. Return
+139.87%
5 Year Est. Return
+217.47%
10 Year Est. Return
+1,125.15%
AUM
$6.96B
AUM Growth
-$310M
Cap. Flow
-$2.61B
Cap. Flow %
-37.54%
Top 10 Hldgs %
33.35%
Holding
260
New
53
Increased
27
Reduced
26
Closed
61

Sector Composition

Rank Sector Weight
1 Industrials 11.79%
2 Communication Services 10.77%
3 Technology 10.27%
4 Consumer Discretionary 9.37%
5 Consumer Staples 7.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRMB
201
Primo Brands
PRMB
$8.54B
-150,000
Closed -$5.32M
FLOC
202
Flowco Holdings
FLOC
$911M
-55,000
Closed -$1.41M
SFD
203
Smithfield Foods
SFD
$9.99B
-50,000
Closed -$1.02M
BBNX
204
Beta Bionics
BBNX
$715M
-31,000
Closed -$379K
MAZE
205
Maze Therapeutics
MAZE
$1.59B
-13,670
Closed -$151K
KRMN
206
Karman Holdings
KRMN
$7.72B
-225,000
Closed -$7.52M
SAIL
207
SailPoint Inc
SAIL
$10.6B
-361,000
Closed -$6.77M
SGI
208
Somnigroup International
SGI
$13.7B
-1,047,690
Closed -$62.7M
KMTS
209
Kestra Medical Technologies
KMTS
$1.55B
-11,000
Closed -$274K
CRWV
210
CoreWeave
CRWV
$49.5B
-192,900
Closed -$17.8M
NMAX
211
Newsmax Inc
NMAX
$1.16B
-8,000
Closed -$668K
BECN
212
DELISTED
Beacon Roofing Supply, Inc.
BECN
-1,654,598
Closed -$205M
ML.WS
213
DELISTED
MoneyLion Inc. Warrants, each whole warrant exercisable 1/30th of a share of Class A common stock at an exercise price of $345.00 per whole share
ML.WS
-517,389
Closed -$137K
ITCI
214
DELISTED
Intra-Cellular Therapies Inc.
ITCI
-3,485,058
Closed -$460M
VCSA
215
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
-1,517,381
Closed -$8.16M

Similar funds

Davidson Kempner Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Davidson Kempner Capital Management held 260 positions worth $6.96B, down 4.3% from $7.27B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Davidson Kempner Capital Management withdrew a net $2.61B in Q2 2025, closing 61 positions and reducing 26 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $460M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 12% of assets, down from 12% a quarter earlier, followed by Communication Services and Technology.

Against the trend, Davidson Kempner Capital Management opened a new position in Blueprint Medicines worth $133M.

  • Davidson Kempner Capital Management's largest Q2 2025 buy was Blueprint Medicines: 1,035,100 shares worth $133M.
  • Davidson Kempner Capital Management added most to Juniper Networks in Q2 2025, an estimated $49.8M increase.
  • Davidson Kempner Capital Management's biggest Q2 2025 reduction was Interpublic Group of Companies, cutting an estimated $135M.
  • Davidson Kempner Capital Management fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $460M.
  • Davidson Kempner Capital Management's ten largest holdings make up 33% of its $6.96B portfolio in Q2 2025.
  • Davidson Kempner Capital Management opened 53 new positions and closed 61 in Q2 2025.
  • Davidson Kempner Capital Management's portfolio value fell 4.3% quarter-over-quarter to $6.96B.

Based on Davidson Kempner Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.